» Articles » PMID: 37072609

Emerging Roles of Non-coding RNAs in Psoriasis Pathogenesis

Overview
Publisher Springer
Date 2023 Apr 18
PMID 37072609
Authors
Affiliations
Soon will be listed here.
Abstract

Psoriasis is a complex genetic skin disorder typically manifested by red, scaly, and itchy plaques most commonly over the scalp, trunk, elbows, and knees. Histopathological features include thickening of the epidermal layer due to hyper-proliferation and abnormal differentiation of epidermal keratinocytes along with infiltration of immune cells in the psoriatic skin. It is a chronic inflammatory relapsing disease, and there is currently no permanent cure for psoriasis. Proper medications can reduce the severity of the disease and improve the quality of life of the patients. While the genetic components of psoriasis pathogenesis are well explored, the full understanding of its epigenetic component remains elusive. Non-coding RNAs (ncRNAs) are documented to regulate various epigenetic processes that lead to the pathogenesis of different diseases including psoriasis. In this review, we have discussed the molecular interplay of different ncRNAs in psoriasis pathogenesis. The roles of microRNAs (miRNAs) in psoriasis are pretty well studied, whereas the roles of long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) are emerging. This review provides ideas covering some of the latest findings of different modes of functions played by those different ncRNAs documented in the literature. As an ever-evolving topic, some works are still ongoing as well as there are several fields that need rigorous scientific ventures. We have proposed the areas which claim more explorations to better understand the roles played by the ncRNAs in psoriasis pathogenesis.

Citing Articles

Psoriasis and Seasonality: Exploring the Genetic and Epigenetic Interactions.

Niedzwiedz M, Skibinska M, Ciazynska M, Noweta M, Czerwinska A, Krzyscin J Int J Mol Sci. 2024; 25(21).

PMID: 39519223 PMC: 11547062. DOI: 10.3390/ijms252111670.


Non-Coding RNA Involved in the Pathogenesis of Atherosclerosis-A Narrative Review.

Kielbowski K, Zychowska J, Bakinowska E, Pawlik A Diagnostics (Basel). 2024; 14(17).

PMID: 39272765 PMC: 11394555. DOI: 10.3390/diagnostics14171981.


WTAP mediated m6A-modified circ_0056856 contributes to the proliferation, migration, and invasion of IL-22-stimulated human keratinocyte by miR-197-3p/CDK1 axis.

Du X, Shi L, Wang B, Zhang G Arch Dermatol Res. 2024; 316(6):208.

PMID: 38787443 DOI: 10.1007/s00403-024-03097-8.


Targeted siRNA Therapy for Psoriasis: Translating Preclinical Potential into Clinical Treatments.

Zhao F, Zhao J, Wei K, Jiang P, Shi Y, Chang C Immunotargets Ther. 2024; 13:259-271.

PMID: 38770264 PMC: 11104385. DOI: 10.2147/ITT.S458800.


Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis.

Rusinol L, Puig L Int J Mol Sci. 2024; 25(2).

PMID: 38256115 PMC: 10815999. DOI: 10.3390/ijms25021042.


References
1.
Abdallah H, Tawfik N, Soliman N, Tag Eldeen L . The lncRNA PRINS-miRNA-mRNA Axis Gene Expression Profile as a Circulating Biomarker Panel in Psoriasis. Mol Diagn Ther. 2022; 26(4):451-465. PMC: 9276574. DOI: 10.1007/s40291-022-00598-y. View

2.
Shehata W, Maraee A, Abd El Monem Ellaithy M, Tayel N, Abo-Ghazala A, Mohammed El-Hefnawy S . Circulating long noncoding RNA growth arrest-specific transcript 5 as a diagnostic marker and indicator of degree of severity in plaque psoriasis. Int J Dermatol. 2021; 60(8):973-979. DOI: 10.1111/ijd.15494. View

3.
Bhat S, Ahmad S, Tajamul Mumtaz P, Malik A, Dar M, Urwat U . Long non-coding RNAs: Mechanism of action and functional utility. Noncoding RNA Res. 2018; 1(1):43-50. PMC: 6096411. DOI: 10.1016/j.ncrna.2016.11.002. View

4.
Bracke S, Desmet E, Guerrero-Aspizua S, Tjabringa S, Schalkwijk J, Van Gele M . Identifying targets for topical RNAi therapeutics in psoriasis: assessment of a new in vitro psoriasis model. Arch Dermatol Res. 2013; 305(6):501-12. DOI: 10.1007/s00403-013-1379-9. View

5.
Chandra A, Ray A, Senapati S, Chatterjee R . Genetic and epigenetic basis of psoriasis pathogenesis. Mol Immunol. 2015; 64(2):313-23. DOI: 10.1016/j.molimm.2014.12.014. View